baber/WOPTO huggingface dataset:
Patent FI-953628-A0 (FI)
Inventor: STARK JUERGEN
IPC: E05F15/60
Filed: 1995-07-28
Abstract: An electromechanically operated door having a control and regulation system for the door, the door for being driven by an electric motor, the movement of the door being controlled by sensors. The control and regulation system is equipped with a microprocessor control. In addition to the normal path of data to the microprocessor control, a dual redundancy is achieved, in that there is a safety monitoring system which receives the same safety-related information as the microprocessor control. This safety monitoring system, for its part, is capable of detecting a fault, i.e. if the microprocessor control system has not shut off the door, the door is shut off by the safety monitoring system, which for its part reports any faults which occur in the system to a fault detection unit, and here again, by means of a redundant shutdown unit, brings the connected motor and thus the door to an immediate stop. In addition to the automatic verification of the safety-related functions, manual verification of the safety functions is also possible. Also contemplated is a control and regulation system, having the above features, for a door.
Patent FI-970445-A0 (FI)
Inventor: DORIN GLENN
IPC: C12N15/09
Filed: 1997-02-03
Abstract: Methods for the production of interferon- beta  polypeptides by bacterial cells, by culturing cells capable of producing IFN- beta  polypeptide under conditions that induce increased production of IFN- beta  polypeptide. Such conditions include, for example, low potassium cation concentration and/or very low sodium cation concentration and/or specific pH ranges.
Patent FI-970752-A0 (FI)
Inventor: BOLTE GERD DR
IPC: C09J175/04
Filed: 1997-02-21
Abstract: PCT No. PCT/EP95/03216 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Aug. 14, 1995 PCT Pub. No. WO96/06124 PCT Pub. Date Feb. 29, 1996The invention relates to polyurethane compositions with a low content of monomeric diisocyanates. Trifunctional isocyanates optionally reduced in their functionality to 3.0+/-0.7 with a monofunctional terminator are preferably used for this purpose. In this way, the compositions contain considerably smaller quantities of readily volatile isocyanates. The compositions are suitable for use as reactive hotmelt adhesives, lamination adhesives, adhesive/sealing compounds, primers and for the production of foam plastics from non-reusable pressurized containers (aerosol cans). The low content of volatile monomeric diisocyanates enables the need for safety measures in the workplace to be significantly reduced, in addition to which the disposal of residues remaining in the containers is made considerably easier.
Patent FI-973065-A0 (FI)
Inventor: BHADESHIA HARSHAD KUMAR DHARAM
IPC: C21D1/02
Filed: 1997-07-18
Abstract: PCT No. PCT/GB96/00034 Sec. 371 Date Sep. 29, 1997 Sec. 102(e) Date Sep. 29, 1997 PCT Filed Jan. 11, 1996 PCT Pub. No. WO96/22396 PCT Pub. Date Jul. 25, 1996A method of producing a wear and rolling contact fatigue resistant bainitic steel product whose microstructure is essentially carbide-free. The method comprises the steps of hot rolling a steel whose composition by weight includes from 0.05 to 0.50% carbon, from 1.00 to 3.00% silicon and/or aluminum, from 0.50 to 2.50% manganese, and from 0.25 to 2.50% chromium, balance iron and incidental impurities, and continuously cooling the steel from its rolling temperature naturally in air or by accelerated cooling.
Patent FI-991484-A0 (FI)
Inventor: SAASTAMOINEN ELJAS
IPC: G01F1/28
Filed: 1999-06-29
Abstract: An arrangement for measuring material flow, particularly concentrate flow, in connection with a flotation cell. The arrangement comprises an elongate sensor element extending essentially over the whole transversal area of the material flow to be measured, and a measuring device for detecting the position of the sensor element.
Patent IL-63924-A0 (IL)
Title: Preparation of 4'-deoxy-daunorubicin and 4'-deoxy-doxorubicin
IPC: C07H15/252
Filed: 1981-09-24
Abstract: A new process for the preparation of the known 4'-deoxydaunorubicin and 4'-deoxydoxorubicin is disclosed. The used starting material is 4'-eip-N-trifluoroacetyldaunorubicin which is converted into 4'-deoxy-4'-iodo-N-trifluoroacetyl-daunorubicin from which 4'-deoxy-daunorubicin can be reductively obtained and eventually transformed, by known methods, into 4'-deoxy-doxorubicin.
Patent IL-67433-A0 (IL)
Title: Water-soluble zinc and aluminium phthalocyanines,their preparation and their use as photoactivators
IPC: C07F5/06
Filed: 1982-12-07
Abstract: The invention relates to novel zinc and aluminium phthalocyanine compounds of the formula   <IMAGE>   wherein MePc is the zinc or aluminium phthalocyanine ring system, M is hydrogen or a salt-forming cation, P1 is hydrogen or a group of the formula -NH-CN or NH-SO2R3 or the salts thereof, wherein R3 is alkyl, aryl or a heterocyclic ring system, R2 is a neutral, non-solubilizing substituent, n is 1 to 4 and each of m and q is 0 to 3 and p is 0 to 4. These compounds are prepared by starting from the corresponding sulfohalides. The novel compounds are used as photoactivators, especially for bleaching and removing stains from textiles and for combating microorganisms in or on organic or inorganic substrates. The invention also relates to bleaching, detergent and soaking and microbicidal compositions which contain the novel phthalocyanine compounds.
Patent IL-71487-A0 (IL)
Title: Method and apparatus for thrusting a shield for use in tunneling
IPC: E21B7/20
Filed: 1984-04-10
Abstract: for thrusting a shield for use in tunneling includes the steps of causing a rotary head (14), provided at the front portion of a shield body (12), an eccentric motion sothat earth, soil or sand covering the front of the shield is pressed away radially of the shield, and exerting a thrust on the shield body during the eccentric motion of said rotary head. Apparatus for carrying outthe method includes a driven crank shaft (22) or a driven eccentric straight shaft, a conical or frustoconical rotary head (14) supported rotatably by the crank or eccentric straight shaft, conveyor for discharging mined material backwardly, and hydraulic jacks for imparting a thrust to the shield bodv.
Patent IL-87055-A0 (IL)
Title: Topical pharmaceutical compositions
IPC: A61K38/00
Filed: 1988-07-08
Abstract: There are provided pharmaceutical compositions for topical transdermal application for the treatment of male impotence and compositions for the treatment of asthma and of hypertension. The active ingredients of such compositions are selected from vasoactive intestinal peptide (VIP), effective derivatives thereof and effective fragments thereof. In the compositions for the treatment of male impotence a transdermally effective conjugate of VIP, its derivatives or fragments coupled to a hydrophobic moiety, is used.
Patent IL-90542-A0 (IL)
Title: Method,kit and reagents for specific binding assays utlizing sensitizer-induced production of detectable signals
IPC: C12Q1/68
Filed: 1989-06-06
Abstract: Specific binding assays are disclosed which utilize a sensitizer as a label. Such sensitizers include any moiety which, when stimulated by "excitation" with radiation of one or more wavelengths or other chemical or physical stimulus (e.g., electron transfer, electrolysis, electroluminescence or energy transfer), will achieve an excited state which (a) upon interaction with molecular oxygen will produce singlet molecular oxygen, or (b) upon interaction with a leucodye will assume a reduced form which can then be returned to its original unexcited state by interaction with molecular oxygen resulting in the production of hydrogen peroxide. Either interaction with the excited sensitizer will, with the addition of other reagents, produce a detectable signal.
Patent IL-93177-A0 (IL)
Title: Heterocyclic nitromethane derivatives
IPC: C07D265/30
Filed: 1990-01-25
Abstract: The invention concerns pharmaceutially useful heterocyclic nitromethane compounds of the formula I:   <IMAGE> I  in which ring Q is a heterocycle of 4 to 7 ring atoms, the fragment completing the ring Q having 2 to 5 atoms, one of which is carbon, oxygen, sulphur or a group of the formula -NRa-, and the remainder are carbon; Ra is hydrogen, (1-6C)alkyl, (2-6C)alkanoyl, trifluoroacetyl, phenyl, benzoyl, or phenyl(1-4C)alkyl, the latter three optionally substituted; and R1R2and R3 are independently hydrogen, hydroxy, (1-6C)alkyl, (1-6C)alkoxy, phenyl, phenoxy or phenyl(1-4C)alkyl, the last three optionally substituted, or two of R1, R2 and R3 situated on adjacent ring carbon atoms and together with said carbon atoms form a benzene ring fused to ring Q, the benzene ring itself optionally substituted, provided that when the fragment completion ring Q is of 3 atoms then at least one of R1, R2 and R3 is hydrogen; and salts thereof. Other aspects of the invention include the production of the novel compounds by analogy processes and pharmaceutical compositions of the novel compounds and of N-(nitromethylsulphonyl)morpholine for use in the treatment of diabetic complications.
Patent IL-95196-A0 (IL)
Title: Method of discontinuous production of l-carnitine by a microbiological process
IPC: C12P13/00
Filed: 1990-07-26
Abstract: The process starts from  gamma -butyrobetaine and/or crotonobetaine.
Patent IL-95736-A0 (IL)
Title: Flat panel display devices
IPC: G09F9/30
Filed: 1990-09-19
Abstract: A flat panel display device includes a backplate (4) and a transparent front face (6) delimiting an hermetically sealed vacuum space and an array (9) of selectively actuable electron-emitting cold cathodes disposed adjacent to, or on the backplate. A stratum (16) including an electron-multiplier (18) is placed in close proximity to the array of cold cathodes. The device also includes a luminescing surface (22) capable of emitting light upon being impinged upon by a pulse of electron beam emerging from the electronic multiplier. One embodiment includes an electron multiplier having an amorphous structure and cold cathodes of the metal-insulator-metal tunnelling type. <IMAGE>
Patent SE-9103812-A0 (SE)
Title: Förfarande för montering av fönster- och dörrbågar
Inventor: RÖNNLUND STELLAN
IPC: F25D23/02
Filed: 1991-12-20
Abstract: • • •• •••• • • • • .10 • •• • • • •• •'I • It• 0••t • I• .*••• ; ••• !, SOKANDE (natnn och adress) TERMOFICIST AB Box 8 164 93KISTA GMBUD (namn) ---TekttOr.-Befitortenblict Tekn.Dr. Tommy Broth% Fil.kand. Else Noren ortenbiad UPPFINNARE (namtz, onoch land) -NOR-ENSPATENT-8-YRA-A8- Box 27034, 102 51 STOCKHOLM Stellan Rinnlund Hallands\iagen 14 191 43SOLLENTUNA UPPFINNINGENS BENAMNING Pbrfarande 55r montering av fonster- och dorrlAgar BEGARAN OM PRIORITET (datum, land oda rummer) STAMANSOKNINGENS NUMMER: BEGARD GELTIGHETSDAG- Vid avdelad eller tabruten ansokan BILAGOR: Kopia av ansiikningshandling Beskrivning i 3 exemplar m3 ritningsblad i 3 exemplardecembe.x Stockholm den 1991 Patentkrav i 3 exemplar Sammandrag i anslutning till fig4TERMOFROS T AB Uverlatclsehancllinggm 0 Fullmakt UnderfullmaktUnderskriftunderfull.makt 1774 utuindsk text AvgiftKr 1.600:- + Kr 300:- (abonnemang) = Kr 1.900:- CJPrioritetshandling 0
Patent AU-PP826499-A0 (AU)
Title: Initiating system for solid polyester granule manufacture
IPC: C08F2/32
Filed: 1999-01-20
Abstract: The invention relates to the use of a diacyl peroxide in combination with an aromatic amine of formula (I) where R1 is C1-C20 alkyl having at least one hydroxy substituent or -(CH'CHR'-O)nH where n is 1 to 10 and each R' is independently selected from H and C1-C3 alkyl; R2 is C1-C20 alkyl optionally substituted with one or more hydroxy groups, or -(CHR'CHR'-O)nH where n=1 to 10; and each R is independently selected from H and C1-C3 alkyl; and Ar is an optionally substituted aryl group; as a redox initiating system in a process for the manufacture of polyester granules by suspension polymerisation. This invention also relates to a process for preparing solid polyester granules using such a redox initiating system.
Patent IL-105064-A0 (IL)
Title: Glycosylation-mediated inhibition of factor x
IPC: A61P29/00
Filed: 1993-03-16
Abstract: Reagents that specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an  alpha 2-6 linkage are able to inhibit the conversion of human Factor X to human Factor Xa. These reagents (SA/Gal/GalNAc binding reagents) as well as other strategies for inhibiting the conversion of Factor X to Factor Xa are useful in treating thrombosis, inflammation and other conditions associated with excess thrombin activity.
Patent IL-106634-A0 (IL)
Title: Method and standard solution for the determination of thyroxine(t4)or triiodothyronine(t3)
IPC: G01N33/96
Filed: 1993-08-09
Abstract: In a process for determining thyroxine (T4) or triiodothyronine (T3) in serum, a standard solution which contains bovine thyroxine-binding globulin (TBG) and thyroxine or triiodothyronine dissolved in a buffer solution is used for calibration.
Patent IL-111647-A0 (IL)
Title: Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
IPC: A61K9/16
Filed: 1994-11-15
Abstract: Sustained-release microparticle composition. The microparticle composition can be formulated to provide extended release over a period of from about 7 days to about 200 days. The microparticles may be formulated with a biodegradable and biocompatible polymer, and an active agent, such as risperidone, 9-hydroxy-risperidone, and pharmaceutically acceptable acid addition salts of the foregoing.
Patent IL-128513-A0 (IL)
Title: Amino acid ester containing azole antifungals
IPC: C07D/
Filed: 1998-02-03
Abstract: The present invention concerns novel compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts thereof and stereochemically isomeric forms thereof, wherein -A-B- forms a bivalent radical of formula -N=CH- (a), -CH=N- (b), -CH=CH- (c), L represents the acyl moiety of an amino acid; D is an azole containing 1,3- or 1,4-dioxolane derivative as broad-spectrum antifungals; their preparation, compositions containing them and their use as a medicine.
Patent IL-133719-A0 (IL)
Title: Method for the production of n-(5-amino-2-cyano-4- fluorophenyl) - sulphonamides and new intermediate products
IPC: C07C253/30
Filed: 1998-07-13
Abstract: The invention relates to a process for preparing N-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides in which, in a first step, 2-amino-4,5-difluoro-benzonitrile is reacted with sulphonyl halides in the presence of an acid acceptor and in the presence of a diluent at temperatures between 0° C. and 150° C. and, in a second step, the N-(2-cyano-4,5-difluoro-phenyl)-sulphon-amides and/or N-(2-cyano-4,5-difluoro-phenyl)-sulphonamides obtained in the first step are as pure substances or as mixtures with ammonia in the presence of a diluent reacted at a temperature between 100° C. and 200° C. The invention furthermore relates to novel intermediates of the process.
Patent IL-145417-A0 (IL)
Title: Detection of mutations in genes by specific lna primers
IPC: C12Q1/68
Filed: 2000-03-17
Abstract: The present invention relates to a method of detecting variant nucleic acid whose nucleotide sequence differs from one another at a single (or more) position(s). The method uses a set of chimeric oligonucleotides containing DNA monomers and monomers of a novel class of DNA analogues, locked nucleic acid (LNA). LNA oligomers obey the Watson-Crick base-pairing rules and form duplexes that are significantly more stable than similar duplexes formed by DNA. The "allele-specific" LNA-containing oligonucleotides wherein the LNA nucleotide(s) are found at the 3' position can be extended by means of enzymes only where the nucleotide(s), which is/are terminal in direction of extension, is/are complementary to the corresponding nucleotides of the nucleic acid (of the one allele) to be detected. Thus discrimination between alleles without subsequent differential hybridization with labelled oligonucleotides is possible. The invention further relates to reagents for performing the methods as well as applications of the method.
Patent IL-145541-A0 (IL)
Title: Waterproofed vapor-permeable sole for shoes
IPC: A43B13/26
Filed: 2001-01-15
Abstract: A waterproofed and vapor-permeable sole for shoes, comprising a tread which is made of leather or similar material and is at least partially covered in an upward region by a membrane made of a material which is permeable to vapor and impermeable to water and is sealed in its peripheral regions with respect to the tread. The tread has through holes in which inserts made of plastic material such as rubber or the like are assembled hermetically, the inserts in turn having through holes.
Patent IL-157144-A0 (IL)
Title: Use of flumazenil to produce a medicament for the treatment of cocaine dependency
IPC: A61P25/36
Filed: 2002-02-08
Abstract: The invention relates to the use of flumazenil to produce a medicament for the treatment of cocaine dependency. The flumazenil can be administered sequentially in small quantities at short intervals until a therapeutically effective quantity for the treatment of cocaine dependency has been administered.
Patent IL-159371-A0 (IL)
Title: Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
IPC: C12N15/09
Filed: 2002-07-01
Abstract: Recombinant lentiviral vectors having a region encoding a functional globin gene; and large portions of the beta-globin locus control regions which include DNase I hypersensitive sites HS2, HS3 and HS4 provides expression of beta-globin when introduced into a mammal, for example a human, in vivo. Optionally, the vector further includes a region encoding a dihydrofolate reductase. The vector may be used in treatment of hemoglobinopathies, including beta-thalessemia and sickle-cell disease. For example, hematopoietic progenitor or stem cells may be transformed ex vivo and then restored to the patient. Selection processes may be used to increase the percentage of transformed cells in the returned population. For example, a selection marker which makes transformed cells more drug resistant than un-transformed cells allows selection by treatment of the cells with the corresponding drug.
Patent IL-159603-A0 (IL)
Title: Locking mechanism for air handler cabinet
IPC: F24F1/00
Filed: 2002-07-11
Abstract: A locking mechanism for an air handling duct which includes a plurality of interconnected modules which together made up the duct. The locking mechanism includes a male retainer contained on a frame member of a first module, with the male retainer having a locking arm adapted to be moved from an unlocked position to a locked position. A complementary female retainer is contained on a frame member of a second module, with the female retainer being in the form of an elongated keyway designed to receive and hold the locking arm in a locked position. Means are provided to move the arm from an unlocked position to a locked position when the male and female retainers are in alignment for locking the modules together.
Patent IL-179831-A0 (IL)
Title: Human autism susceptibility gene encoding prkcb1 and uses thereof
IPC: C12Q1/68
Filed: 2006-12-04
Abstract: The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the PRKCB 1 gene on chromosome 16 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the PRKCBI gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, childhood disintegrative disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay or language impairment, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases.
Patent IL-187389-A0 (IL)
Title: Nucleic acid molecule encoding a conjugate for treating activated immune cells
IPC: C07K14/52
Filed: 2007-11-15
Abstract: The present invention provides a conjugate, comprising a targeted agent comprising a cytotoxic agent or a nucleic acid encoding a cytotoxic agent and a chemokine receptor targeting agent selected from a chemokine or a portion thereof, wherein the conjugate binds to a chemokine receptor resulting in internalization of the linked targeted agent in cells bearing the receptor, wherein the chemokine receptor targeting agent specifically binds to chemokine receptors on immune effector cells.
Patent IL-193276-A0 (IL)
Title: Process for preparing 1-halo-2,7-naphthyridinyl derivatives
Filed: 2008-08-06
Abstract: A process for preparing 1-halo-2,7-naphthyridinyl derivatives is described (I), wherein X is Cl or Br; which process comprises the following steps: (i) reaction of a 3-cyano-4-methylpyridine derivative of formula (A): with a compound of formula (II), in the presence of an N,N-dimethylformamide diC1-6alkylacetal; to give an enamine derivative of formula (III), (ii) cyclisation of the enamine of formula (III), to obtain the compound of formula (IV), (iii) reaction of the compound of formula (IV) with a halogenating agent, to obtain a compound of formula (I).
Patent RO-132024-A0 (RO)
Title: Supporting and moving mechanism for extending sofa
Inventor: ZANI MAURILLO
IPC: A47C17/22
Filed: 2016-09-07
Abstract: The invention relates to a supporting and moving mechanism for an extending sofa which can be thereby converted into bed. According to the invention, the mechanism consists of a base frame (1) and three support frames (2, 3 and 4) joined to one another by some joining elements (5, 6), as follows: at the top part of the base frame (1) there is the head support frame (2) articulated to the back support frame (3) by some moving mechanisms (7A and 7D), where the back support frame (3) is articulated to the leg support frame (4) by other moving mechanisms (7E and 7G) and the movement of the frames (2, 3 and 4), using the mechanisms (7A and 7G), upon the folding-unfolding action, passes from the completely open position, in which the sofa has a bed function, to the completely closed position, in which it has a sofa function, through various intermediate positions, i.e. partly closed at 25%, partly closed at 50% and partly closed at 75%.
Patent RO-134447-A0 (RO)
Title: In vivo process for determining the protective effect of a nutraceutic against oxidative stress
Inventor: VAMANU EMANUEL
IPC: G01N33/50
Filed: 2019-06-03
Abstract: The invention relates to an in vivo process for determining the protective effect of a functional supplement or medicine against oxidative stress. According to the invention, the process consists in the stages of preparing the target probiotic microbial strain - S. cerevisiae, obtaining viable yeast biomass, obtaining free radical generating solutions, performing the in-vivo test, determining the critical point representing the equilibrium value of the concentration of free radicals over which the tested product has no protective effect of preserving the viability of the tested strain.
Patent RO-136035-A0 (RO)
Title: Signaling method with led lamps in road motor-vehicles
Inventor: NAE CĂTĂLIN
IPC: B60Q1/34
Filed: 2022-06-16
Abstract: The invention relates to a method of signaling the change of direction of travel or the hazard stop for road motor-vehicles. According to the invention, the method consists in equipping a vehicle (1) with rectangular or circular signaling lamps (2, 3, 4, 5, 6, 7), each comprising SMD LED light modules arranged in several pairs of arrowheads oriented to the left and to the right, which can be switched off, can signal the turning to the right, to the left or the state of hazard stop, the angle of each arrowhead being between 30° and 90°.